Pharmaceuticals, Biotechnology and Life Sciences
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the appointments of Elizabeth (Betsy) Garofalo, M.D….
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the appointments of Elizabeth (Betsy) Garofalo, M.D….
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the appointments of Elizabeth (Betsy) Garofalo, M.D….
Feasibility arrangement to test GreenLight Bioscience Inc’s COVID-19 messenger RNA vaccine candidate as a shelf-stable dry powder formulation using TFF Pharmaceuticals’ Thin-Film Freezing technology.
An easily reconstituted and shelf-stable dry powde…
Feasibility arrangement to test GreenLight Bioscience Inc’s COVID-19 messenger RNA vaccine candidate as a shelf-stable dry powder formulation using TFF Pharmaceuticals’ Thin-Film Freezing technology.
An easily reconstituted and shelf-stable dry powde…
DUBLIN–(BUSINESS WIRE)–The “Psilocybin – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“Psilocybin – Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights a…
DUBLIN–(BUSINESS WIRE)–The “Psilocybin – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“Psilocybin – Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights a…
DUBLIN–(BUSINESS WIRE)–The “Psilocybin – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
“Psilocybin – Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights a…
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn O’Connor, chief executive …
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn O’Connor, chief executive …